Scientists test new prostate disease drug

Mar 27, 2008

A Canadian-headquartered biopharmaceutical company is conducting the second Phase 3 study of a new drug designed to treat prostate disease.

Aeterna Zentaris Inc. said the double-blind study to be conducted in Europe will test the clinical effectiveness of cetrorelix, a luteinizing hormone-releasing drug for the treatment of benign prostatic hyperplasia, or BPH -- a non-cancerous enlargement of the prostate that causes disturbances in urination.

In the second Phase 3 study, 400 male patients will enter a four-week, no-treatment observation period and then be randomly assigned to either receive cetrorelix or a placebo. Effectiveness will based on a test that measures the severity and stability of voiding prostate symptoms.

The company's first study of the effectiveness of cetrorelix began in April 2007 and is continuing in Canada, Europe and the United States.

Copyright 2008 by United Press International

Explore further: National Cancer Institute supports next-generation Austrian HPV vaccine

add to favorites email to friend print save as pdf

Related Stories

Universe may face a darker future

5 minutes ago

New research offers a novel insight into the nature of dark matter and dark energy and what the future of our Universe might be.

Analysing animal anatomy using augmented reality

15 minutes ago

The University of Liverpool's School of Veterinary Science is utilising cutting edge technology to allow students to analyse animals' internal anatomy, using their smartphones.

Confirming a 3-D structural view of a quasar outflow

24 minutes ago

A team of astronomers have observed a distant gravitationally-lensed quasar (i.e., an active galactic nucleus) with the Subaru Telescope and concluded that the data indeed present a 3-D view of the structure ...

Recommended for you

A new tool in drug overdose prevention

Oct 30, 2014

The Center for Disease Control reported earlier this month that the heroin overdose death rate across 28 states it surveyed doubled between 2010 and 2012. This sharp increase and the chilling statistics that say more than 11 ...

Nasal spray treats heroin overdose

Oct 28, 2014

"Every year, drug overdoses are responsible for roughly 1000 ambulance calls in Oslo," says Arne Skulberg, an anaesthesiologist, a PhD candidate at NTNU and the 2014 winner of Norway's Researcher Grand Prix ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.